Cost effectiveness of a new strategy to identify HNPCC patients

Gut

Volumn 54, Issue 1, 2005, Pages 97-102

  Kievit, W ^a   De Bruin, J H F M ^a   Adang, E M M ^a   Severens, J L ^b   Kleibeuker, J H ^d   Sijmons, R H ^d   Ruers, T J ^a   Nagengast, F M ^a   Vasen, H F A ^c   Van Krieken, J H J M ^a   Ligtenberg, M J L ^a   Hoogerbrugge, N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; COLON ADENOMA; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FAMILY HISTORY; HETEROZYGOTE; HUMAN; LIFE EXPECTANCY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SIBLING;

COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; GENETIC SCREENING; GENOMIC INSTABILITY; HEALTH CARE COSTS; HUMANS; MICROSATELLITE REPEATS; MUTATION; NETHERLANDS; SENSITIVITY AND SPECIFICITY;

EID: 19944397798     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.039123     Document Type: Article

References (41)

1. Summerton N. Diagnosing cancer in primary care. Abingdon: Radcliffe, 1999.
2. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
3. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
4. Lynch H. Chapelle de la A. Genetic susceptibility to non-palypasis colorectal cancer. J Med Gen 1999;36:801-18.
5. Church J. McGannon E. Family history of colorectal cancer: how often and how accurately is it recorded. Dis Colon Rectum 2000;43:1540-4.
6. Sijmons RH, Boonstra AE, Reefhuis J, et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 2000;8:181-6.
7. Katballe N, Juul S, Christensen M, et al. Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members. Br J Surg 2001;88:1228-33.
8. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
9. Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.
10. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
11. Lynch HT, de la Chapelle CA. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
12. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
13. American Gastroenterology Association. American Gastroenterology Association Medical Position Statement: Hereditary Colorectal Cancer and Genetic Testing. Gastroenterology 2001;121:195-7.
14. Cravo ML, Fidalgo PO, Lage PA, et al. Validation and simplification of Bethesda guidelines for identifying apparently sporadic forms of colorectal carcinoma with microsatellite instability. Cancer 1999;85:779-85.
15. Briggs AH, Wonderling DE, Mooney CZ. "Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. "Health Econ 1994;3:95-104.
16. Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997;6:217-27.
17. Wagner A, Barrows A, Wijnen JT, et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003;72:1088-100.
18. Lynch HT, Chapelle de la A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-18.
19. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press, 1997.
20. Aaltonen L, Salovaara R, Chapelle de la A. Incidence of HNPCC and the feasibility of molecular screening for disease. N Eng J Med 1998;21:1481-7.
21. Gardiello FM, Brensinger JD, Pedersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.
22. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpalypasis colorectal cancer. J Clin Oncol 2000;18:2193-200.
23. Chan TL, Yuen ST, Chung LP, et al. Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer. J Natl Cancer Inst 1999;91:1221-6.
24. Fornasarig M, Viel A, Valentini M, et al. Microsatellite instability and MLH1 and MSH2 germline defects are related to clinicopathological features in sporadic colorectal cancer. Oncol Rep 2000;7:39-43.
25. Ho JW, Yuen ST, Chung LP, et al. Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients. Int J Cancer 2000;89:356-60.
26. Montera M, Resta N, Simone C, et al. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients. J Med Genet 2000;37:7e.
27. Terdiman JP, Gum JR Jr, Conrad PG, et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 2001;120:21-30.
28. Wahlberg SS, Schmeits J, Thomas G, et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002;62:3485-92.
29. Kievit W, Bruin de JHFM, Adang EMM, et al. Current clinical selection strategies for identification of HNPCC families are inadequate: a meta-analysis. Clin Genet 2004;65:308-16.
30. Järvinen H, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for CRC in families with HNPCC. Gastroenterology 2000;118:829-34.
31. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economiscne evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen, 2000.
32. Reyes CM, Allen BA, Terdiman JP, et al. Comparison of selection strategies for genetic testing of patients with hereditary nonpolypasis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer 2002;95:1848-56.
33. Ramsey SD, Clarke L, Etzioni R, et al. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135:577-88.
34. Vasen HF, van Ballegooijen M, Buskens E, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998;82:1632-7.
35. Syngal S, Weeks JC, Schrag D, et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998;129:787-96.
36. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
37. Rijcken FE, Mourits MJ, Kleibeuker JH, et al. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003;91:74-80.
38. Dove-Edwin I, Boks D, Goff S, et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002;94:1708-12.
39. Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002;34:541-7.
40. Wahlberg SS, Schmeits J, Thomas G, et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpalypasis colon cancer families. Cancer Res 2002;62:3485-92.
41. Unmar A, Risinger JI, Hawk ET, et al. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004;4:153-8.